Zoghbi Huda Y — SEC Form 4 filings

SEC reporting owner CIK 1681643. 4 Form 4 filings on record with FilingPulse; latest filed 2026-08-12.

Transaction summary — filings shown

Covers all 4 filings on record, filed 2025-01-06 to 2026-08-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
REGENERON PHARMACEUTICALS, INC. (REGN)Director412 legs · 2,438 sh · $1,919,8128

Form 4 filings — Zoghbi Huda Y

FiledFormIssuerReported transactionsSource
2026-08-124REGENERON PHARMACEUTICALS, INC. (REGN)Option exercise (M): 800 @ $376.69 · Sale (S): 800 @ $800 · Option exercise (M): 800 (derivative) @ $0EDGAR
2026-02-234REGENERON PHARMACEUTICALS, INC. (REGN)Option exercise (M): 1,638 @ $376.69 · Sale (S): 49 @ $774.68 · Sale (S): 50 @ $775.50 · Sale (S): 53 @ $778.47 · Sale (S): 208 @ $779.55 · Sale (S): 331 @ $780.45 · +7 moreEDGAR
2026-01-064REGENERON PHARMACEUTICALS, INC. (REGN)Grant/award (A): 155 @ $0 · Grant/award (A): 1,962 (derivative) @ $0EDGAR
2025-01-064REGENERON PHARMACEUTICALS, INC. (REGN)Grant/award (A): 166 @ $0 · Grant/award (A): 1,958 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1681643 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →